TABLE 2.

Relationship between predictors of outcome and mortality at 28 days

Patient dataa	No. of patient deaths/total n (%)	P value	OR	95% CI
Organism types
E. coli	7/33 (21.2)	0.25b	0.6	0.2-1.5
P. aeruginosa	18/46 (39.1)	0.10	1.8	0.9-3.7
Enterobacter spp.	5/23 (21.7)	0.38	0.6	0.2-1.8
Klebsiella spp.	7/23 (30.4)	0.92	1.05	0.4-2.7
Proteus spp.	1/4 (25)	0.84	0.8	0.08-7.8
Serratia spp.	5/21 (23.8)	0.54	0.7	0.3-2.1
All others	2/7 (28.6)	0.95	0.95	0.2-5.1
Polymicrobial	7/19 (36.8)	0.46	1.5	0.6-3.9
APACHE-II scores
3-19	12/85 (14.1)
20-24	10/38 (26.3)	0.11c	2.2	0.8-5.6
25-29	12/22 (54.5)	0.0002	2.7	1.6-4.5
30-53	12/16 (75)	<0.0001	2.6	1.7-4.0
Sources of bacteremia
CVC	1/14 (7.1)	0.09d	0.2	0.02-1.3
UTI	5/26 (19.2)	0.22	0.5	0.2-1.5
Pneumonia	13/34 (38.2)	0.22	1.6	0.8-3.6
Other	2/9 (22.2)	0.62	0.7	0.1-3.3
Unknown	31/93 (33.3)	0.24	1.5	0.8-2.8
Creatinine clearance rates
>100 ml/min	4/28 (14.3)
60-100 ml/min	7/41 (17.1)	0.76e	1.2	0.3-4.7
<60 ml/min	21/57 (36.8)	0.039	3.5	1.1-11.5
CVVHD	12/18 (66.7)	0.0007	12.0	2.8-50.8
HD	7/30 (23.3)	0.28	2.1	0.6-7.9
Immune status
Competent	16/60 (26.7)
Compromised	36/116 (31)	0.55f	1.2	0.6-2.5
Ages
≤64	28/105 (26.7)
≥65	24/71 (33.8)	0.31g	1.4	0.7-2.7
Modes of therapy
Monotherapy	21/73 (28.8)
Combination therapy	31/102 (30.4)	0.82h	1.08	0.56-2.09

^aAbbreviations: CVC, central venous catheter; UTI, urinary tract infection; CVVHD, continuous venovenous hemodialysis; HD, hemodialysis.

^bP value compared to that of all other organisms.

^cP value compared to that of score range 3-19.

^dP value compared to that of all other sources.

^eP value compared to that of creatinine clearance of >100 ml/min.

^fP value compared to competent status.

^gP value compared to those aged ≤64.

^hP value compared to that of monotherapy.